Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Echocardiographic study of the haemodynamic effects of remifentanil with and without glycopyrrolate in healthy children
2006-000460-90Phase 3Completed
- Sponsor
- Ghent University Hospital
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of remifentanil and glycopyrronium in bradyarrhythmia and hypotension (2 arms), sponsored by Ghent University Hospital. Primary endpoints: Haemodynamic effects on cardiac function and Blood pressure changes. Started Feb 2006; status: completed.
02
Drugs
remifentanilglycopyrronium
03
Conditions
bradyarrhythmiahypotension
Beyond the preview
Go deeper on 2006-000460-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000460-90.